Article Text

Download PDFPDF
Which antibiotic first in meningococcal disease? A national survey
  1. L Hudson1,
  2. N Tickner2,
  3. P Salt1
  1. 1Department of Paediatric and Adolescent Medicine, University College Hospital, London, UK
  2. 2Pharmacy Department, University College Hospital, London, UK
  1. Correspondence to Dr Lee Hudson, T11 Office, University College Hospital, 235 Euston Rd, London NW1 2BU, UK; leehudson{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

In response to reports of deaths involving calcium–ceftriaxone precipitates in neonates and young infants,1 The Medicines and Healthcare Products Regulatory Agency in the UK has warned that ceftriaxone should not be used with calcium-containing solutions and is contraindicated entirely in neonates.2 Draft guidelines on the management of meningococcal disease by The National Institute for Health and Clinical Excellence available online recommend avoiding ceftriaxone at the same time as calcium infusions and caution against use in the under 3-month age group.3 We performed an anonymised postal survey from …

View Full Text


  • Funding University College Hospital London stationery was used and postage.

  • Competing interests None.

  • Ethics approval We discussed our project with our local ethics committee who deemed it audit not research and not requiring further approval.

  • Provenance and peer review Not commissioned; externally peer reviewed.